IMATIN 400 (Imatinib 400 mg) by Knoll is a targeted therapy medication used primarily for the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), which work by blocking specific proteins that promote the growth of cancer cells.
How It Works?
Imatinib inhibits the BCR-ABL tyrosine kinase, an abnormal enzyme responsible for uncontrolled cancer cell growth in CML. By blocking this enzyme, IMATIN 400 helps slow or stop cancer progression. It also targets c-KIT and PDGFR proteins, making it effective for treating GISTs and other cancers.
Dosage :
Recommended Dose: Typically 400-600 mg once daily with food and water.
Dosage may vary based on medical condition and doctor’s prescription.
Do not crush or break tablets; swallow whole.
Benefits :
- Effective for Chronic Myeloid Leukemia (CML)
- Treats Gastrointestinal Stromal Tumors (GISTs)
- Targeted Therapy
- Improves Survival Rates
Side Effects :
Some users may experience:
- Nausea
- Fatigue
- Swelling
- Muscle cramps
- Diarrhea
Serious effects (rare):
Liver problems
Fluid retention
Low blood cell count.
Seek medical attention if experiencing severe side effects.
Conclusion :
IMATIN 400 (Imatinib 400 mg) is a life-saving targeted therapy for leukemia and certain tumors, helping patients manage their condition and improve quality of life. Always use under medical supervision and follow the prescribed dosage for optimal results.
Reviews
There are no reviews yet.